The "Global Cold Plasma In Healthcare Market" is predicted to reach at a high CAGR of 15.4% during the forecast period (2022-2029).
Plasma can be defined as partially ionized gas which contains an approximately equal number of positive and negative particles. Plasmas can be classified into hot plasmas (also defined as near-equilibrium plasmas) and cold plasmas (nonequilibrium plasmas). In cold plasmas, the electron temperature is relatively high (1–10 eV) while the translational energy of heavy particles remains very low, with temperature close to room one, and the ionization degree is typically low. The electric field is applied to a gas; energy is transferred more efficiently to the free electrons naturally present in the gas than to the ions. The accelerated electrons then transfer the energy to heavier particles.
In Biomedicine, cold plasma is used to treat teeth, skin, and sterilize medical devices. In the food industry, cold plasma is used in the packaging process and food production.
Source: DataM Intelligence Analysis (2020)
The Cold Plasma In Healthcare Market is expected to grow due to the benefits of cold plasma techniques and their use in wound healing. The cold plasma in the field of medicine is thus blooming quickly as cold plasma has the ability to kill bacteria and prevent infections.
Benefits of cold plasma technology
Cold plasma technology has diverse applications in several industries. Cold plasma is a novel non-thermal technology that uses energetic, reactive gases to inactivate contaminating microbes on meats, fruits, poultry and vegetables. The ability of cold atmospheric plasma to inactivate bacteria recently gained more relevance because modern society has been facing several serious healthcare challenges.
Cold plasma in infection prevention
Cold plasma has demonstrated broad bactericidal activity regardless of the bacterial species and resistance in vitro and in vivo. The development of cold plasma now allows Application to viable tissue. The efficacy of a cold plasma device in reducing bacterial carriage and pain in a patient with chronic nasopharyngeal and external auditory canal infection after cholesteatoma surgery is reported.
As per the World Health Organization 2020, more than 1.35 million individuals pass on consistently because of streetcar accidents and mishaps. Street traffic wounds are the main source of death among individuals mature somewhere in the range of 15 and 29 years. Consistently the existence of more than 1.35 million individuals are sliced short because of the streetcar accident. In this manner, since there are countless injury and wound administration cases noticed yearly, the appropriation pace of cold plasma is required to be high for twisted recuperating across the medical clinics and medical services offices.
High investment and limited commercialization
There is a high investment required for cold plasma technology as the equipment used in this is very costly and requires special operating conditions. As a result, cold plasma has witnessed limited commercialization. The successful applications of cold plasma have been limited to a few sectors. The less awareness of cold plasma has also inhibited the greater adoption of this technology.
COVID-19 Impact Analysis
With the rising COVID-19scenerio, the demand for cold plasma has increased. A cold plasma Regime could prevent these superinfections and reduce hospital staff risk of becoming infected with the coronavirus. Preliminary tests carried out by terraplasma medical GmbH, the subsidiary of the Max Planck spin-off terraplasma, suggest that cold atmospheric plasma (i.e., weakly ionised air) can render Sars-CoV-2 harmless in cell cultures.
To find if cold plasma can actually help treat Covid-19, investigations in both cell cultures and Covid-19 patients have been initiated together with various partners. Cold atmospheric plasma – plasma produced near room temperature – potentially effectively deactivating the SARS-CoV-2 virus. With an increasing number of cases, it has been found that cold plasma is being considered as a treatment option for COVID-19. The demand for plasma Regime is thus increasing.
On the basis of application, the cold plasma in the healthcare market is divided into wound healing, blood coagulation, dentistry, cancer treatment and other medical applications.
The wound healing segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)
Cold plasma is an innovative approach to wound healing. In vitro and initial clinical studies for chronic wounds in animals and humans have shown that CAP decreases their bacterial load and promotes healing without significant side effects on normal tissue. Additionally, CAP was found to facilitate the transformation of the chronic wound from becoming a stagnating wound or an acute healing wound through modulation of the inflammation stimulation of different growth factors and tissue-reactive species interaction.
Moreover, as per Germany Federal Statistical Office 2020 report, currently, there is about 83 million population in Germany. Of these, 16.2 million population are above 67 years of age, and it is projected to reach 21.4 million by 2040. With the increase in the geriatric population, there is an increasing number of diabetic populations, resulting in chronic wounds such as foot ulcers and thus boosting the overall market.
Based on regime, the Cold Plasma In Healthcare Market into low-pressure plasma and atmospheric cold plasma.
Source: DataM Intelligence Analysis (2020)
The low-pressure plasma is to witness growth in the forecast period.
The low-pressure cold plasma is estimated to hold the largest share in the market and is also expected to grow in the forecast period. A wide array of cold plasma systems operating at atmospheric pressure or in low-pressure treatment chambers are under development. Low-pressure plasmas are used for decontamination/sterilization in the food industry and medicine or the specific modification of the surface properties of materials.
North America is expected to hold a significant share in the market and is expected to do the same in the forecast period.
North America has been found to dominate the market due to key companies investing in the market and the availability of various products. Furthermore, the growing prevalence of trauma cases and cancer patient pool is driving the growth of the market in North America.
In July 2020, Grifols, a leading producer of plasma-derived medicines, announced the signing of an agreement to acquire a Montreal-based plasma fractionation unit and two purification units of GC Pharma Group, as well as 11 plasma collection centers in the U.S. for USD 460.0 Million.
On the other hand, the Asia-Pacific region is expected to see growth in the forecast period. With the rising demand for plasma therapies and rising production of polymers. Many global companies are focusing on developing and expanding their R&D capabilities and distribution networks in this region.
The Cold Plasma In Healthcare Market is one of the most competitive markets. Some of the key companies in the global cold plasma market are U.S. Medical Innovations, LLC, Bovie Medical Corporation, Neoplas Tools GmbH, Europlasma N.V., and P2i Limited.
Adtech Plasma Technology
Overview: Established in 1985 in Fukuyama, Japan, Adtec Plasma Technology originally worked to develop and manufacture various control boards. By early 1991, they had begun selling High-Frequency Plasma Generation Equipment for semiconductor processes – this has remained the core of our business ever since. We’re one of the World’s leading suppliers of RF Plasma products to the semiconductor and display industries.
Also based at Fukuyama Head Office, the Adtec Innovation department constantly strives to innovate and develop new technology, most notably within cold atmospheric pressure gas plasma technologies. In February 2020, Adtech Plasma Technology initiated a new project collaborating with Hull York Medical School to test gas plasma on osteomyelitis bone infections. The project will assist in establishing a laboratory testing model for evaluating and optimizing plasma treatment for osteomyelitis biofilm infections.
Product Portfolio: The company’s portfolio comprises high-frequency plasma generation equipment and RF plasma products.
The Cold Plasma In Healthcare Market report would provide access to an approx. 53 market data table, 180 figures.
Get your free sample proposal with a single click!